GlobeImmune's IPO

GlobeImmune raised a round of funding on July 02, 2014. Investors include Public.

GlobeImmune is a biopharmaceutical company focused on developing products for the treatment of infectious disease and and oncology based on its proprietary Tarmogen platform. Tarmogens are believed to…

Articles about GlobeImmune's IPO: